Key result
taVNS fails to improve baroreflex sensitivity vs sham during orthostatic stress.
Why the study?
Baroreflex dysfunction and autonomic imbalance are key features of hypertension that current pharmacological treatments often fail to address, motivating investigation of taVNS effects on autonomic regulation during blood pressure perturbation.
Does transcutaneous auricular vagus nerve stimulation (taVNS) improve baroreflex sensitivity and heart rate variability during orthostatic stress in healthy normotensive adults?
RCT (n=32)
Single-blind
computer-based randomization procedure for 1:1 distribution
No
Does transcutaneous auricular vagus nerve stimulation (taVNS) improve baroreflex sensitivity and heart rate variability during orthostatic stress in healthy normotensive adults?
A single 90-minute session of transcutaneous auricular vagus nerve stimulation (taVNS) did not significantly improve baroreflex sensitivity or most continuous heart rate variability parameters during an orthostatic challenge in healthy adults compared to sham.
taVNS does not improve baroreflex sensitivity during orthostatic stress; challenges acute autonomic efficacy and leaves open effects in hypertensive patients.
Baroreflex dysfunction and autonomic imbalance are key pathophysiological features of hypertension, but current pharmacological approaches often fail to address these neural mechanisms. This study investigated whether transcutaneous auricular vagus nerve stimulation (taVNS) affects autonomic regulation during blood pressure perturbation. In a randomized, single-blind, sham-controlled, crossover design experiment, 32 normotensive adults received 90-min taVNS or sham exposure. Blood pressure perturbation was induced with the head-up tilt test (supine–tilt–supine). Baroreflex sensitivity (BRS) was analyzed only during the 10-minute tilt phase, whereas heart rate variability (HRV) was analyzed across four 5-minute segments (S-baseline, early-tilt, late-tilt, recovery). In the direct crossover analysis of the primary BRS outcome, pre-to-post changes did not differ significantly between taVNS and sham, and the baseline-adjusted sensitivity analysis yielded the same conclusion. Among the secondary HRV outcomes, differences averaged across analysis segments were significant only for SDNN and pNN30, whereas no analysis-segment-specific interaction was significant. Descriptive within-visit comparisons showed increases in BRS and several HRV measures during the taVNS visit. These findings provide preliminary evidence compatible with cardiovagal modulation during orthostatic stress, but do not establish a taVNS-specific improvement in BRS or blood pressure regulation. Further research involving patient cohorts and longitudinal study protocols is needed.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) conducted an RCT in Healthy normotensive adults (n=32). Transcutaneous auricular vagus nerve stimulation vs. Sham stimulation was evaluated on Baroreflex sensitivity (up-slope) during the 10-minute tilt phase (MD 1.46 ms/mmHg, 95% CI -1.32 to 4.24, p=0.302). Transcutaneous auricular vagus nerve stimulation did not significantly improve baroreflex sensitivity compared to sham during orthostatic stress (mean difference 1.46 ms/mmHg, p=0.302).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: